Financhill
Back

Seelos Therapeutics Stock Predictions

Seelos Therapeutics Stock Forecast

  • Is Seelos Therapeutics Stock Undervalued?
    The current Seelos Therapeutics [SEEL] share price is $0.20. The Score for SEEL is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
  • SEEL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Seelos Therapeutics Stock Go Up Next Year?

Data Unavailable

Seelos Therapeutics Stock Rating

Data Unavailable

Seelos Therapeutics Stock Price History

Is SEEL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEEL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
seelostherapeutics.com

52-Week Data

52-Week High:
57.58
52-Week Low:
0.18

Prediction Charts

Market Cap:
1.42M
Price in USD:
0.20
Volume:
724.22K
Beta:
1.34

Technical Analysis

SMA50:
0.34
SMA100:
0.85
SMA200:
4.46
52-Wk Change:
-99.92%

Stock Predictions

  • Is Seelos Therapeutics stock public?
    Yes, Seelos Therapeutics is a publicly traded company.
  • What is the Seelos Therapeutics stock quote today?
    The Seelos Therapeutics stock price is 0.20 USD today.
  • How to buy Seelos Therapeutics stock online?
    You can buy Seelos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-30 0.29 0.30 0.30 0.29
Sep-3 0.29 0.26 0.31 0.25
Sep-4 0.26 0.24 0.27 0.23
Sep-5 0.25 0.23 0.26 0.23
Sep-6 0.23 0.22 0.24 0.20
Sep-9 0.22 0.21 0.22 0.21
Sep-10 0.21 0.20 0.22 0.20
Sep-11 0.20 0.20 0.21 0.18
Sep-12 0.20 0.19 0.21 0.19
Sep-13 0.19 0.20 0.20 0.18
Sep-16 0.20 0.19 0.21 0.19
Sep-17 0.19 0.23 0.25 0.19
Sep-18 0.22 0.20 0.22 0.19
Sep-19 0.21 0.20 0.22 0.19

Seelos Therapeutics Earnings

Data Unavailable

Seelos Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $16.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

* Seelos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.